JPMorgan Chase & Co’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Sell |
313,493
-18,890
| -6% | -$1.01M | ﹤0.01% | 1846 |
|
|
2025
Q1 | $13.5M | Sell |
332,383
-195,824
| -37% | -$7.93M | ﹤0.01% | 1975 |
|
|
2024
Q4 | $14.7M | Buy |
528,207
+40,161
| +8% | +$1.12M | ﹤0.01% | 1964 |
|
|
2024
Q3 | $14M | Sell |
488,046
-54,221
| -10% | -$1.56M | ﹤0.01% | 1944 |
|
|
2024
Q2 | $12.7M | Buy |
542,267
+216,868
| +67% | +$5.09M | ﹤0.01% | 1946 |
|
|
2024
Q1 | $8.22M | Buy |
325,399
+172,521
| +113% | +$4.36M | ﹤0.01% | 2248 |
|
|
2023
Q4 | $3.57M | Sell |
152,878
-561,700
| -79% | -$13.1M | ﹤0.01% | 2780 |
|
|
2023
Q3 | $36.1M | Buy |
714,578
+377,258
| +112% | +$19.1M | ﹤0.01% | 1160 |
|
|
2023
Q2 | $15.7M | Buy |
337,320
+125,852
| +60% | +$5.88M | ﹤0.01% | 1700 |
|
|
2023
Q1 | $8.09M | Buy |
211,468
+28,153
| +15% | +$1.08M | ﹤0.01% | 2146 |
|
|
2022
Q4 | $10M | Sell |
183,315
-52,214
| -22% | -$2.86M | ﹤0.01% | 1908 |
|
|
2022
Q3 | $8.02M | Buy |
235,529
+702
| +0.3% | +$23.9K | ﹤0.01% | 2021 |
|
|
2022
Q2 | $2.22M | Buy |
234,827
+188,960
| +412% | +$1.79M | ﹤0.01% | 2938 |
|
|
2022
Q1 | $651K | Sell |
45,867
-1,957
| -4% | -$27.8K | ﹤0.01% | 3851 |
|
|
2021
Q4 | $1.01M | Sell |
47,824
-1,006
| -2% | -$21.3K | ﹤0.01% | 3663 |
|
|
2021
Q3 | $1.09M | Sell |
48,830
-2,139
| -4% | -$47.8K | ﹤0.01% | 3551 |
|
|
2021
Q2 | $1.27M | Buy |
50,969
+2,933
| +6% | +$72.8K | ﹤0.01% | 3500 |
|
|
2021
Q1 | $1.39M | Buy |
48,036
+1,491
| +3% | +$43.3K | ﹤0.01% | 3446 |
|
|
2020
Q4 | $1.2M | Sell |
46,545
-11,639
| -20% | -$300K | ﹤0.01% | 3275 |
|
|
2020
Q3 | $1.83M | Sell |
58,184
-5,237
| -8% | -$164K | ﹤0.01% | 2809 |
|
|
2020
Q2 | $1.58M | Buy |
63,421
+12,172
| +24% | +$303K | ﹤0.01% | 2805 |
|
|
2020
Q1 | $1.09M | Sell |
51,249
-54,481
| -52% | -$1.15M | ﹤0.01% | 2903 |
|
|
2019
Q4 | $2.35M | Buy |
105,730
+21,763
| +26% | +$483K | ﹤0.01% | 2610 |
|
|
2019
Q3 | $1.91M | Buy |
+83,967
| New | +$1.91M | ﹤0.01% | 2757 |
|